Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2.

Journal of biomedicine & biotechnology

Scholl S, Squiban P, Bizouarne N, Baudin M, Acres B, Von Mensdorff-Pouilly S, Shearer M, Beuzeboc P, Van Belle S, Uzielly B, Pouillart P, Taylor-Papadimitriou J, Miles D.
PMID: 12975534
J Biomed Biotechnol. 2003;2003(3):194-201. doi: 10.1155/S111072430320704X.

MUC1 is expressed by glandular epithelial cells. It is overexpressed in the majority of breast tumours, making it a potential target for immune therapy. The objectives of the present study were to evaluate the anti-tumour activity and tolerance of...

Cite
Scholl S, Squiban P, Bizouarne N, et al. Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2. J Biomed Biotechnol. 2003;2003(3):194-201doi: 10.1155/S111072430320704X.
Scholl, S., Squiban, P., Bizouarne, N., Baudin, M., Acres, B., Von Mensdorff-Pouilly, S., Shearer, M., Beuzeboc, P., Van Belle, S., Uzielly, B., Pouillart, P., Taylor-Papadimitriou, J., & Miles, D. (2003). Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2. Journal of biomedicine & biotechnology, 2003(3), 194-201. https://doi.org/10.1155/S111072430320704X
Scholl, Susy, et al. "Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2." Journal of biomedicine & biotechnology vol. 2003,3 (2003): 194-201. doi: https://doi.org/10.1155/S111072430320704X
Scholl S, Squiban P, Bizouarne N, Baudin M, Acres B, Von Mensdorff-Pouilly S, Shearer M, Beuzeboc P, Van Belle S, Uzielly B, Pouillart P, Taylor-Papadimitriou J, Miles D. Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2. J Biomed Biotechnol. 2003;2003(3):194-201. doi: 10.1155/S111072430320704X. PMID: 12975534; PMCID: PMC400208.
Copy Download .nbib Format: NLM
Two-dimensional wavelet processor.

Applied optics

Ouzieli I, Mendlovic D.
PMID: 21127594
Appl Opt. 1996 Oct 10;35(29):5839-46. doi: 10.1364/AO.35.005839.

An optical implementation of the two-dimensional (2-D) wavelet transform and inverse wavelet transform is performed in real time by the exploitation of a new multichannel system that processes the different daughter wavelets separately. The so-coined wavelet-processor system relies on...

Cite
Ouzieli I, Mendlovic D. Two-dimensional wavelet processor. Appl Opt. 1996;35(29):5839-46doi: 10.1364/AO.35.005839.
Ouzieli, I., & Mendlovic, D. (1996). Two-dimensional wavelet processor. Applied optics, 35(29), 5839-46. https://doi.org/10.1364/AO.35.005839
Ouzieli, I, and Mendlovic, D. "Two-dimensional wavelet processor." Applied optics vol. 35,29 (1996): 5839-46. doi: https://doi.org/10.1364/AO.35.005839
Ouzieli I, Mendlovic D. Two-dimensional wavelet processor. Appl Opt. 1996 Oct 10;35(29):5839-46. doi: 10.1364/AO.35.005839. PMID: 21127594.
Copy Download .nbib Format: NLM
Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review.

Frontiers in oncology

Militello AM, Zielli T, Boggiani D, Michiara M, Naldi N, Bortesi B, Zanelli P, Uliana V, Giuliotti S, Musolino A.
PMID: 31456944
Front Oncol. 2019 Aug 13;9:759. doi: 10.3389/fonc.2019.00759. eCollection 2019.

Sensitivity to endocrine therapy of patients with estrogen receptor (ER)-positive metastatic breast cancer and germline

Cite
Militello AM, Zielli T, Boggiani D, et al. Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review. Front Oncol. 2019;9:759doi: 10.3389/fonc.2019.00759.
Militello, A. M., Zielli, T., Boggiani, D., Michiara, M., Naldi, N., Bortesi, B., Zanelli, P., Uliana, V., Giuliotti, S., & Musolino, A. (2019). Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review. Frontiers in oncology, 9759. https://doi.org/10.3389/fonc.2019.00759
Militello, Anna Maria, et al. "Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review." Frontiers in oncology vol. 9 (2019): 759. doi: https://doi.org/10.3389/fonc.2019.00759
Militello AM, Zielli T, Boggiani D, Michiara M, Naldi N, Bortesi B, Zanelli P, Uliana V, Giuliotti S, Musolino A. Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review. Front Oncol. 2019 Aug 13;9:759. doi: 10.3389/fonc.2019.00759. eCollection 2019. PMID: 31456944; PMCID: PMC6700293.
Copy Download .nbib Format: NLM
Multiple Outbreaks of Niacin (Nicotinic Acid) Intoxication Due to Addition of Meat "Enhancer" to Products by Two Different Meat Processors.

Journal of food protection

Gross EM, Roth Y, Uzieli V, Haas A, Toker M, Belmaker E, Barkay A, Ab L, Toker M.
PMID: 31071768
J Food Prot. 1992 Feb;55(2):116-119. doi: 10.4315/0362-028X-55.2.116.

Five outbreaks of facial flushing accompanied by a feeling of warmth and pruritus were reported in people eating commercially prepared frozen ground beef or processed veal steaks. The outbreaks occurred during a seven-month period in Israel. In all instances...

Cite
Gross EM, Roth Y, Uzieli V, et al. Multiple Outbreaks of Niacin (Nicotinic Acid) Intoxication Due to Addition of Meat "Enhancer" to Products by Two Different Meat Processors. J Food Prot. 1992;55(2):116-119doi: 10.4315/0362-028X-55.2.116.
Gross, E. M., Roth, Y., Uzieli, V., Haas, A., Toker, M., Belmaker, E., Barkay, A., Ab, L., & Toker, M. (1992). Multiple Outbreaks of Niacin (Nicotinic Acid) Intoxication Due to Addition of Meat "Enhancer" to Products by Two Different Meat Processors. Journal of food protection, 55(2), 116-119. https://doi.org/10.4315/0362-028X-55.2.116
Gross, Ellis M, et al. "Multiple Outbreaks of Niacin (Nicotinic Acid) Intoxication Due to Addition of Meat "Enhancer" to Products by Two Different Meat Processors." Journal of food protection vol. 55,2 (1992): 116-119. doi: https://doi.org/10.4315/0362-028X-55.2.116
Gross EM, Roth Y, Uzieli V, Haas A, Toker M, Belmaker E, Barkay A, Ab L, Toker M. Multiple Outbreaks of Niacin (Nicotinic Acid) Intoxication Due to Addition of Meat "Enhancer" to Products by Two Different Meat Processors. J Food Prot. 1992 Feb;55(2):116-119. doi: 10.4315/0362-028X-55.2.116. PMID: 31071768.
Copy Download .nbib Format: NLM
PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: the role of salvage chemo-immunotherapy combination.

Immunotherapy

Gelsomino F, Facchinetti F, Sisi M, Zielli T, Tiseo M, Ardizzoni A.
PMID: 33533279
Immunotherapy. 2021 Apr;13(5):363-369. doi: 10.2217/imt-2020-0280. Epub 2021 Feb 03.

Novel treatment strategies incorporating PD-1/PD-L1 inhibitors in the first-line setting of advanced non-small-cell lung cancer (NSCLC) provided relevant improvements in survival outcomes. Among NSCLC patients with PD-L1 tumor proportion score ≥50%, identifying the ones to be addressed to pembrolizumab...

Cite
Gelsomino F, Facchinetti F, Sisi M, et al. PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: the role of salvage chemo-immunotherapy combination. Immunotherapy. 2021;13(5):363-369doi: 10.2217/imt-2020-0280.
Gelsomino, F., Facchinetti, F., Sisi, M., Zielli, T., Tiseo, M., & Ardizzoni, A. (2021). PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: the role of salvage chemo-immunotherapy combination. Immunotherapy, 13(5), 363-369. https://doi.org/10.2217/imt-2020-0280
Gelsomino, Francesco, et al. "PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: the role of salvage chemo-immunotherapy combination." Immunotherapy vol. 13,5 (2021): 363-369. doi: https://doi.org/10.2217/imt-2020-0280
Gelsomino F, Facchinetti F, Sisi M, Zielli T, Tiseo M, Ardizzoni A. PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: the role of salvage chemo-immunotherapy combination. Immunotherapy. 2021 Apr;13(5):363-369. doi: 10.2217/imt-2020-0280. Epub 2021 Feb 03. PMID: 33533279.
Copy Download .nbib Format: NLM
Wavelet-transform-based composite filters for invariant pattern recognition.

Applied optics

Zalevsky Z, Ouzieli I, Mendlovic D.
PMID: 21102692
Appl Opt. 1996 Jun 10;35(17):3141-7. doi: 10.1364/AO.35.003141.

A wavelet-transformation-based optical processor for performing invariant pattern recognition is suggested. It contains a composite filter that consists of several wavelet daughter functions derived from the reference object. The intensity of the correlation peak is determined to be invariant...

Cite
Zalevsky Z, Ouzieli I, Mendlovic D. Wavelet-transform-based composite filters for invariant pattern recognition. Appl Opt. 1996;35(17):3141-7doi: 10.1364/AO.35.003141.
Zalevsky, Z., Ouzieli, I., & Mendlovic, D. (1996). Wavelet-transform-based composite filters for invariant pattern recognition. Applied optics, 35(17), 3141-7. https://doi.org/10.1364/AO.35.003141
Zalevsky, Z, et al. "Wavelet-transform-based composite filters for invariant pattern recognition." Applied optics vol. 35,17 (1996): 3141-7. doi: https://doi.org/10.1364/AO.35.003141
Zalevsky Z, Ouzieli I, Mendlovic D. Wavelet-transform-based composite filters for invariant pattern recognition. Appl Opt. 1996 Jun 10;35(17):3141-7. doi: 10.1364/AO.35.003141. PMID: 21102692.
Copy Download .nbib Format: NLM
Two-dimensional wavelet transform achieved by computer-generated multireference matched filter and Dammann grating.

Applied optics

Mendlovic D, Ouzieli I, Kiryuschev I, Marom E.
PMID: 21068938
Appl Opt. 1995 Dec 10;34(35):8213-9. doi: 10.1364/AO.34.008213.

A two-dimensional wavelet transform is optically performed in real time by use of a new multichannel system that processes the different daughter wavelets separately. The system, which is able to handle every wavelet function, relies on a Dammann grating...

Cite
Mendlovic D, Ouzieli I, Kiryuschev I, et al. Two-dimensional wavelet transform achieved by computer-generated multireference matched filter and Dammann grating. Appl Opt. 1995;34(35):8213-9doi: 10.1364/AO.34.008213.
Mendlovic, D., Ouzieli, I., Kiryuschev, I., & Marom, E. (1995). Two-dimensional wavelet transform achieved by computer-generated multireference matched filter and Dammann grating. Applied optics, 34(35), 8213-9. https://doi.org/10.1364/AO.34.008213
Mendlovic, D, et al. "Two-dimensional wavelet transform achieved by computer-generated multireference matched filter and Dammann grating." Applied optics vol. 34,35 (1995): 8213-9. doi: https://doi.org/10.1364/AO.34.008213
Mendlovic D, Ouzieli I, Kiryuschev I, Marom E. Two-dimensional wavelet transform achieved by computer-generated multireference matched filter and Dammann grating. Appl Opt. 1995 Dec 10;34(35):8213-9. doi: 10.1364/AO.34.008213. PMID: 21068938.
Copy Download .nbib Format: NLM
Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study.

Clinical Medicine Insights. Oncology

Buti S, Perrone F, Zielli T, Mazzaschi G, Casartelli C, Leonetti A, Milanese G, Silva M, Eufrasia Ledda R, Musolino A, Pucci F, Bersanelli M, Tiseo M.
PMID: 34526833
Clin Med Insights Oncol. 2021 Sep 08;15:11795549211043427. doi: 10.1177/11795549211043427. eCollection 2021.

BACKGROUND: Coronavirus disease (COVID-19), an acute respiratory syndrome caused by a novel severe acute respiratory syndrome coronavirus (SARS-CoV-2), has rapidly spread worldwide, significantly affecting the outcome of a highly vulnerable group such as cancer patients. The aim of the...

Cite
Buti S, Perrone F, Zielli T, et al. Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study. Clin Med Insights Oncol. 2021;15:11795549211043427doi: 10.1177/11795549211043427.
Buti, S., Perrone, F., Zielli, T., Mazzaschi, G., Casartelli, C., Leonetti, A., Milanese, G., Silva, M., Eufrasia Ledda, R., Musolino, A., Pucci, F., Bersanelli, M., & Tiseo, M. (2021). Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study. Clinical Medicine Insights. Oncology, 1511795549211043427. https://doi.org/10.1177/11795549211043427
Buti, Sebastiano, et al. "Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study." Clinical Medicine Insights. Oncology vol. 15 (2021): 11795549211043427. doi: https://doi.org/10.1177/11795549211043427
Buti S, Perrone F, Zielli T, Mazzaschi G, Casartelli C, Leonetti A, Milanese G, Silva M, Eufrasia Ledda R, Musolino A, Pucci F, Bersanelli M, Tiseo M. Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study. Clin Med Insights Oncol. 2021 Sep 08;15:11795549211043427. doi: 10.1177/11795549211043427. eCollection 2021. PMID: 34526833; PMCID: PMC8436296.
Copy Download .nbib Format: NLM
Post-operative management after total ankle arthroplasty: A systematic review of the literature.

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons

Mazzotti A, Viglione V, Gerardi S, Bonelli S, Zielli S, Geraci G, Faldini C.
PMID: 34088605
Foot Ankle Surg. 2021 May 28; doi: 10.1016/j.fas.2021.05.013. Epub 2021 May 28.

BACKGROUND: Currently, there is no consensus on the most appropriate post-operative management for patients undergoing total ankle arthroplasty. The aim of this study is therefore to offer a systematic review of the pertaining literature to identify current post-operative protocols...

Cite
Mazzotti A, Viglione V, Gerardi S, et al. Post-operative management after total ankle arthroplasty: A systematic review of the literature. Foot Ankle Surg. 2021;doi: 10.1016/j.fas.2021.05.013.
Mazzotti, A., Viglione, V., Gerardi, S., Bonelli, S., Zielli, S., Geraci, G., & Faldini, C. (2021). Post-operative management after total ankle arthroplasty: A systematic review of the literature. Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons, . https://doi.org/10.1016/j.fas.2021.05.013
Mazzotti, A, et al. "Post-operative management after total ankle arthroplasty: A systematic review of the literature." Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons vol. (2021). doi: https://doi.org/10.1016/j.fas.2021.05.013
Mazzotti A, Viglione V, Gerardi S, Bonelli S, Zielli S, Geraci G, Faldini C. Post-operative management after total ankle arthroplasty: A systematic review of the literature. Foot Ankle Surg. 2021 May 28; doi: 10.1016/j.fas.2021.05.013. Epub 2021 May 28. PMID: 34088605.
Copy Download .nbib Format: NLM
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14).

Frontiers in oncology

Maruzzo M, Verzoni E, Vitale MG, Dionese M, Buti S, Galli L, Zivi A, Watutantrige-Fernando S, Zielli T, Zanardi E, Sabbatini R, Basso U, Zagonel V, Procopio G.
PMID: 34900742
Front Oncol. 2021 Nov 25;11:787835. doi: 10.3389/fonc.2021.787835. eCollection 2021.

BACKGROUND: Thyroid hormone impairment, represented as an alteration in levels of thyroid hormones and a lower fT3/fT4 ratio, has been correlated with a worse prognosis for both cancer and non-cancer patients. The role of baseline thyroid function in patients...

Cite
Maruzzo M, Verzoni E, Vitale MG, et al. Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14). Front Oncol. 2021;11:787835doi: 10.3389/fonc.2021.787835.
Maruzzo, M., Verzoni, E., Vitale, M. G., Dionese, M., Buti, S., Galli, L., Zivi, A., Watutantrige-Fernando, S., Zielli, T., Zanardi, E., Sabbatini, R., Basso, U., Zagonel, V., & Procopio, G. (2021). Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14). Frontiers in oncology, 11787835. https://doi.org/10.3389/fonc.2021.787835
Maruzzo, Marco, et al. "Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)." Frontiers in oncology vol. 11 (2021): 787835. doi: https://doi.org/10.3389/fonc.2021.787835
Maruzzo M, Verzoni E, Vitale MG, Dionese M, Buti S, Galli L, Zivi A, Watutantrige-Fernando S, Zielli T, Zanardi E, Sabbatini R, Basso U, Zagonel V, Procopio G. Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14). Front Oncol. 2021 Nov 25;11:787835. doi: 10.3389/fonc.2021.787835. eCollection 2021. PMID: 34900742; PMCID: PMC8655227.
Copy Download .nbib Format: NLM
Traumatic Cuboid Dislocation. The Potential Role of Plantar Ligaments Integrity in Facilitating Reduction: A Case Report.

JBJS case connector

Mazzotti A, Bonelli S, Zielli S, Arceri A, Viglione V, Faldini C.
PMID: 34170855
JBJS Case Connect. 2021 Jun 25;11(2). doi: 10.2106/JBJS.CC.20.00683.

CASE: A 56-year-old male patient sustained a traumatic cuboid medioplantar dislocation associated with a lateral cuneiform fracture. The patient was treated with open reduction and fixation using 2 temporary Kirschner wires. During surgery, the plantar ligament apparatus was found...

Cite
Mazzotti A, Bonelli S, Zielli S, et al. Traumatic Cuboid Dislocation. The Potential Role of Plantar Ligaments Integrity in Facilitating Reduction: A Case Report. JBJS Case Connect. 2021;11(2)doi: 10.2106/JBJS.CC.20.00683.
Mazzotti, A., Bonelli, S., Zielli, S., Arceri, A., Viglione, V., & Faldini, C. (2021). Traumatic Cuboid Dislocation. The Potential Role of Plantar Ligaments Integrity in Facilitating Reduction: A Case Report. JBJS case connector, 11(2), . https://doi.org/10.2106/JBJS.CC.20.00683
Mazzotti, Antonio, et al. "Traumatic Cuboid Dislocation. The Potential Role of Plantar Ligaments Integrity in Facilitating Reduction: A Case Report." JBJS case connector vol. 11,2 (2021). doi: https://doi.org/10.2106/JBJS.CC.20.00683
Mazzotti A, Bonelli S, Zielli S, Arceri A, Viglione V, Faldini C. Traumatic Cuboid Dislocation. The Potential Role of Plantar Ligaments Integrity in Facilitating Reduction: A Case Report. JBJS Case Connect. 2021 Jun 25;11(2). doi: 10.2106/JBJS.CC.20.00683. PMID: 34170855.
Copy Download .nbib Format: NLM
Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib.

Anti-cancer drugs

Minari R, Leonetti A, Gnetti L, Zielli T, Ventura L, Bottarelli L, Lagrasta C, La Monica S, Petronini PG, Alfieri R, Tiseo M.
PMID: 33675607
Anticancer Drugs. 2021 Aug 01;32(7):758-762. doi: 10.1097/CAD.0000000000001064.

Osimertinib is a third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) used both as the first-line treatment of EGFR-mutated non-small cell lung cancer patients and in second-line after T790M-positive disease progression to first- or second-generation TKIs. Unfortunately, patients unavoidably...

Cite
Minari R, Leonetti A, Gnetti L, et al. Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib. Anticancer Drugs. 2021;32(7):758-762doi: 10.1097/CAD.0000000000001064.
Minari, R., Leonetti, A., Gnetti, L., Zielli, T., Ventura, L., Bottarelli, L., Lagrasta, C., La Monica, S., Petronini, P. G., Alfieri, R., & Tiseo, M. (2021). Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib. Anti-cancer drugs, 32(7), 758-762. https://doi.org/10.1097/CAD.0000000000001064
Minari, Roberta, et al. "Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib." Anti-cancer drugs vol. 32,7 (2021): 758-762. doi: https://doi.org/10.1097/CAD.0000000000001064
Minari R, Leonetti A, Gnetti L, Zielli T, Ventura L, Bottarelli L, Lagrasta C, La Monica S, Petronini PG, Alfieri R, Tiseo M. Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib. Anticancer Drugs. 2021 Aug 01;32(7):758-762. doi: 10.1097/CAD.0000000000001064. PMID: 33675607.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries